BMS-933043 / BMS - LARVOL DELTA

BMS-933043, a Selective α7 nAChR Partial Agonist for the Treatment of Cognitive Deficits Associated with Schizophrenia. (PubMed) - ACS Med Chem Lett - "In vivo activity was demonstrated in a preclinical model of cognitive impairment, mouse novel object recognition. BMS-933043 has completed Phase I clinical trials."

Journal • Alzheimer's Disease • Biosimilar • CNS Disorders • Schizophrenia